CD8A and lung cancer: Even CCL19, transcribed by fibroblasts, inhibits the growth of lung cancer by promoting local anti-tumor T cell response [51] and CXCL11 is known to be used as an enhancer of vaccine-induced CD8+ T cellular immunity [52].